Literature DB >> 9402051

Mammalian glial cells in culture synthesize acetylcholine.

I Wessler1, T Reinheimer, H Klapproth, F J Schneider, K Racké, R Hammer.   

Abstract

In the present study we demonstrate that acetylcholine is synthesized by cultured mammalian glial cells identified by cell-type specific markers. Primary cultures of rat brain astrocytes or microglia contained 2.0 and 1.6 pmol acetylcholine/10(6) cells on average respectively. Astrocyte cultures established from neonatal mouse brain contained even more acetylcholine (about 80 pmol acetylcholine/10(6) cells). Primary cultures of rat brain astrocytes showed choline acetyltransferase (ChAT) enzyme activity of 3 nmol/mg protein/h; ChAT activity was blocked by 10 microM bromoacetylcholine. In conclusion, these data demonstrate the synthesis of the "neurotransmitter" acetylcholine in cultured glial cells, a finding which opens a new view upon the role of acetylcholine in mammalian brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402051     DOI: 10.1007/pl00005107

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  Excitatory nicotinic and desensitizing muscarinic (M2) effects on C-nociceptors in isolated rat skin.

Authors:  N Bernardini; S K Sauer; R Haberberger; M J Fischer; P W Reeh
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

2.  Ethanol inhibits neuritogenesis induced by astrocyte muscarinic receptors.

Authors:  Marina Guizzetti; Nadia H Moore; Gennaro Giordano; Kathryn L VanDeMark; Lucio G Costa
Journal:  Glia       Date:  2010-09       Impact factor: 7.452

3.  Ethanol impairs muscarinic receptor-induced neuritogenesis in rat hippocampal slices: Role of astrocytes and extracellular matrix proteins.

Authors:  Gennaro Giordano; Marina Guizzetti; Khoi Dao; Hayley A Mattison; Lucio G Costa
Journal:  Biochem Pharmacol       Date:  2011-08-23       Impact factor: 5.858

4.  Choline transporter-like protein 4 (CTL4) links to non-neuronal acetylcholine synthesis.

Authors:  Pingfang Song; Stephen S Rekow; Corey-Ayne Singleton; Harmanjatinder S Sekhon; Gregory A Dissen; Minerva Zhou; Barbara Campling; Jon Lindstrom; Eliot R Spindel
Journal:  J Neurochem       Date:  2013-06-25       Impact factor: 5.372

Review 5.  Muscarinic receptor agonists and antagonists: effects on cancer.

Authors:  Eliot R Spindel
Journal:  Handb Exp Pharmacol       Date:  2012

6.  Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).

Authors:  Qingnan Zhao; Xiajing Gu; Chun Zhang; Qin Lu; Hongzhuan Chen; Lu Xu
Journal:  Cancer Biol Ther       Date:  2015-03-16       Impact factor: 4.742

Review 7.  Astrocytic and microglial nicotinic acetylcholine receptors: an overlooked issue in Alzheimer's disease.

Authors:  Saeed Sadigh-Eteghad; Alireza Majdi; Javad Mahmoudi; Samad E J Golzari; Mahnaz Talebi
Journal:  J Neural Transm (Vienna)       Date:  2016-06-04       Impact factor: 3.575

8.  Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures.

Authors:  Roberta De Simone; Maria Antonietta Ajmone-Cat; Daniela Carnevale; Luisa Minghetti
Journal:  J Neuroinflammation       Date:  2005-01-25       Impact factor: 8.322

9.  A novel muscarinic antagonist R2HBJJ inhibits non-small cell lung cancer cell growth and arrests the cell cycle in G0/G1.

Authors:  Nan Hua; Xiaoli Wei; Xiaoyan Liu; Xiaoyun Ma; Xinhua He; Rengong Zhuo; Zhe Zhao; Liyun Wang; Haitao Yan; Bohua Zhong; Jianquan Zheng
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Upregulating nonneuronal cholinergic activity decreases TNF release from lipopolysaccharide-stimulated RAW264.7 cells.

Authors:  Yi Lv; Sen Hu; Jiangyang Lu; Ning Dong; Qian Liu; Minghua Du; Huiping Zhang
Journal:  Mediators Inflamm       Date:  2014-03-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.